| The Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call Transcript |
The Oncology Institute, Inc. (NASDAQ:TOI ) Q1 2025 Earnings Conference Call May 14, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - Chief Executive Officer Rob Carter - Chief Financial Officer Conference Call Participants David Larsen - BTIG Yuan Zhi - B. Riley Bill Sutherland - The Benchmark Company Robert LeBoyer - NOBLE Capital Markets Operator Good afternoon and welcome to The Oncology Institute's First Quarter 2025 Earnings Conference Call. |
seekingalpha.com |
2025-05-15 02:58:06 |
Czytaj oryginał (ang.) |
| The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer |
CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Dr. Jeffrey Langsam will assume the role of enterprise Chief Clinical Officer effective May 13th, 2025. The CCO role will oversee therapeutics including pathway and procurement decisions, utilization management, and MSO practice clinical engagement. Dr. Langsam joins TOI from Cigna Healthcare, where he was the National Director of Oncology and a Senior Medical Director in the Specialty Pharmacy Division. He previously served as a Regional Medical Director at Aetna, and was clinical faculty at the University of Connecticut where he was a practicing oncologist for many years. |
globenewswire.com |
2025-05-14 20:05:00 |
Czytaj oryginał (ang.) |
| Topicus.com Inc. Announces Election of Members of the Board of Directors |
TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (“Topicus” or the “Corporation”) (TSXV: TOI) is pleased to announce the election of each of the five director nominees listed in the Corporation's management proxy circular dated March 28, 2025, John Billowits, Alex Macdonald, Lori O'Neill, Donna Parr and Robin van Poelje, to the Corporation's board of directors at its May 13, 2025 annual general meeting of shareholders (the “AGM”). |
globenewswire.com |
2025-05-13 23:08:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference |
CERRITOS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in B. Riley's 25th Annual Institutional Investor Conference in Marina Del Rey, CA on May 21st, 2025. |
globenewswire.com |
2025-05-13 20:05:00 |
Czytaj oryginał (ang.) |
| Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 |
TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the first quarter ended March 31, 2025. Please note that all amounts referred to in this press release are in Euros unless otherwise stated. |
globenewswire.com |
2025-05-07 21:03:00 |
Czytaj oryginał (ang.) |
| Topicus.com Inc. Defers Release Date for First Quarter Results |
TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) (the “Company”) announced today that the release of its first quarter results will be rescheduled. The Company will defer the release of its results from the originally planned date of May 2, 2025 in order to allow the Company to finalize its analysis and accounting for certain Q1 2025 complex transactions impacting the condensed consolidated interim financial statements. |
globenewswire.com |
2025-05-01 21:48:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call |
CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). |
globenewswire.com |
2025-04-23 12:00:00 |
Czytaj oryginał (ang.) |
| Topicus.com Inc. Announces Release Date for First Quarter Results |
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its first quarter results on May 2, 2025. |
globenewswire.com |
2025-04-14 22:57:00 |
Czytaj oryginał (ang.) |
| Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings |
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:00 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:30 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Tuesday, May 13, 2025 at 9:00 a.m. EST using a virtual meeting format, with proceedings conducted solely via live audio webcast. |
globenewswire.com |
2025-04-09 12:14:00 |
Czytaj oryginał (ang.) |
| Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings |
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:00 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:30 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Tuesday, May 13, 2025 at 9:00 a.m. EST using a virtual meeting format, with proceedings conducted solely via live audio webcast. |
globenewswire.com |
2025-04-09 12:13:00 |
Czytaj oryginał (ang.) |
| TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 |
CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents. |
globenewswire.com |
2025-03-31 12:00:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript |
The Oncology Institute, Inc. (NASDAQ:TOI ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO Conference Call Participants Yuan Zhi - B. Riley Robert LeBoyer - NOBLE Capital Markets Operator Good afternoon, and welcome to The Oncology Institute's Fourth Quarter and Full-Year 2024 Earnings Conference Call. |
seekingalpha.com |
2025-03-25 20:28:13 |
Czytaj oryginał (ang.) |
| The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 |
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024. |
globenewswire.com |
2025-03-24 08:01:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute Announces $16.5 million Private Placement |
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors for a private placement that is expected to result in gross proceeds of approximately $16.5 million, before deducting placement agent fees and offering expenses (the “Private Placement”). The Private Placement includes participation from existing investors, as well as members of the Company's management team and Board of Directors and is expected to close on March 26, 2025, subject to customary closing conditions. |
globenewswire.com |
2025-03-24 08:00:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call |
CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). |
globenewswire.com |
2025-03-04 10:00:00 |
Czytaj oryginał (ang.) |
| Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Fourth Quarter and Year Ended December 31, 2024 |
TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the fourth quarter and year ended December 31, 2024. Please note that all amounts referred to in this press release are in Euros unless otherwise stated. |
globenewswire.com |
2025-02-26 18:57:00 |
Czytaj oryginał (ang.) |
| Topicus.com Inc. Announces Release Date for Fourth Quarter Results |
TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its fourth quarter results on February 26, 2025. |
globenewswire.com |
2025-02-11 18:55:00 |
Czytaj oryginał (ang.) |
| Florida Blue enhances cancer care for thousands of members |
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care |
globenewswire.com |
2024-12-18 18:05:00 |
Czytaj oryginał (ang.) |
| Grapevine Saves The Oncology Institute Millions On Healthcare Supplies |
Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs |
globenewswire.com |
2024-11-21 09:00:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript |
The Oncology Institute, Inc. (NASDAQ:TOI ) Q3 2024 Earnings Conference Call November 13, 2024 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO Operator Good afternoon and welcome to The Oncology Institute's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. |
seekingalpha.com |
2024-11-13 21:25:26 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc. |
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-11-08 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc. |
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-11-07 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology |
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-11-06 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc. |
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-11-05 15:15:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call |
CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financial results after the market close on Wednesday, November 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). |
globenewswire.com |
2024-11-04 21:09:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology |
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-11-04 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into The Oncology Institute, Inc. |
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-11-01 15:15:00 |
Czytaj oryginał (ang.) |
| Constellation Software Inc. and Topicus.com Inc. Announce Results for Topicus.com Inc. for the Third Quarter Ended September 30, 2024 |
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the third quarter ended September 30, 2024. Please note that all amounts referred to in this press release are in Euros unless otherwise stated. |
globenewswire.com |
2024-10-31 19:04:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc |
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-10-31 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc. |
NEW YORK, NY / ACCESSWIRE / October 30, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-10-30 15:30:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute Inc. |
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-10-29 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Partners, Inc. |
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Partners, Inc.. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. |
accesswire.com |
2024-10-28 15:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc. |
NEW YORK, NY / ACCESSWIRE / October 23, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-10-23 17:15:00 |
Czytaj oryginał (ang.) |
| The Oncology Institute Joins Lantern's Cancer Care Network of Excellence |
CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern's leading specialty care platform. Now, Lantern members will have access to cancer care at any of The Oncology Institute's state-of-the-art community clinics across 5 states. |
globenewswire.com |
2024-10-23 12:00:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology |
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-10-22 17:15:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology |
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own The Oncology Institute, Inc. ("TOI" or the "Company") (NASDAQ:TOI) stock purchased prior to November 9, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as DFP Healthcare Acquisitions Corp. (DFPH), and whether the Board of TOI harmed stockholders, and whether all material facts had been properly disclosed to stockholders. |
accesswire.com |
2024-10-16 17:15:00 |
Czytaj oryginał (ang.) |
| Topicus.com Inc. Announces Release Date for Third Quarter Results |
TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its third quarter results on October 31, 2024. |
globenewswire.com |
2024-10-16 00:51:00 |
Czytaj oryginał (ang.) |